title: Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet.
abstract: Previous studies suggested that endogenous glucagon-like peptide 2 (GLP-2) is dispensable for the regulation of glucose homeostasis under normal conditions, while it can play a beneficial role in obesity conditions. The purpose of the present study was to investigate whether chronic treatment with Gly2-GLP-2, a stable analogue of GLP-2, can have an impact on glycaemic and lipid control in mice fed a high-fat diet (HFD), an animal model of human obesity and insulin resistance. HFD mice were treated once a day with Gly2-GLP-2 for 4 weeks. Body weight, food intake, fasting glucose, intraperitoneal glucose tolerance, insulin-induced glucose clearance, glucose-stimulated insulin secretion, β-cell mass, plasma lipid metabolic profile, and lipid deposition in the liver were examined. In untreated HFD mice, fasting glucose levels, glucose tolerance, glucose-stimulated plasma insulin and sensibility to exogenous insulin were deteriorating with time and β-cell mass increased. In Gly2-GLP-2-treated mice, we found significant increase in glucose tolerance and exogenous insulin sensitivity, reduction in glucose-stimulated plasma insulin and in the increase in β-cell mass in comparison with pair-aged HFD untreated animals. The chronic treatment with the peptide was not associated with remarkable improvements of dyslipidemia and it did not prevent liver fat accumulation and the presence of microvesicular steatosis. In conclusion, the results of the present study suggest, for the first time, that Gly2-GLP-2 may produce glucose metabolic benefits in mice with diet-induced obesity. The mechanisms underlying the beneficial impact of GLP-2 on glucose metabolism remain to be established.
authors.affiliation: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Baldassano
authors.affiliation: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Amato
authors.affiliation: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy.
authors.forename: Gaetano Felice
authors.initials: GF
authors.lastname: Caldara
authors.affiliation: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy. flavia.mule@unipa.it.
authors.forename: Flavia
authors.initials: F
authors.lastname: Mulè
mesh_terms: D000818:Animals; D059305:Diet, High-Fat; D004353:Drug Evaluation, Preclinical; D053767:Glucagon-Like Peptide 2 / Q000819:agonists*; D044882:Glucose Metabolism Disorders / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects; D008297:Male; D008810:Mice, Inbred C57BL; D010179:Pancreas / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D011897:Random Allocation
chemical_list: D053767:Glucagon-Like Peptide 2; D008055:Lipids; D010455:Peptides; C494910:teduglutide
keywords: GLP-2; Insulin resistance; Obesity; Pancreatic islets
references.citation: Diabetologia. 2013 Aug;56(8):1752-60
references.pmid: 23636640
references.citation: J Pharmacol Exp Ther. 2010 May;333(2):574-83
references.pmid: 20167840
references.citation: J Clin Invest. 2003 Jan;111(2):225-30
references.pmid: 12531878
references.citation: J Endocrinol. 2013 Aug 28;218(3):R25-36
references.pmid: 23833274
references.citation: Science. 2005 Mar 25;307(5717):1909-14
references.pmid: 15790843
references.citation: Gut. 1999 Jan;44(1):81-6
references.pmid: 9862830
references.citation: Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G1-8
references.pmid: 21527727
references.citation: Aliment Pharmacol Ther. 2013 Jan;37(1):18-36
references.pmid: 23121085
references.citation: Regul Pept. 2012 Oct 10;178(1-3):95-101
references.pmid: 22809889
references.citation: Endocrinology. 2009 Sep;150(9):4033-43
references.pmid: 19497974
references.citation: J Endocrinol. 2014 Mar 07;221(1):29-37
references.pmid: 24443715
references.citation: Diabetes Metab Syndr Obes. 2014 Dec 04;7:587-91
references.pmid: 25506234
references.citation: Gut. 2009 Aug;58(8):1091-103
references.pmid: 19240062
references.citation: J Clin Biochem Nutr. 2010 May;46(3):212-23
references.pmid: 20490316
references.citation: Endocrinology. 2009 Feb;150(2):592-9
references.pmid: 18845625
references.citation: Islets. 2010 Nov-Dec;2(6):353-6
references.pmid: 21099337
references.citation: Clin Exp Gastroenterol. 2014 Dec 10;7:489-95
references.pmid: 25525380
references.citation: Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G274-85
references.pmid: 24875097
references.citation: Peptides. 2011 Aug;32(8):1587-92
references.pmid: 21771622
references.citation: J Clin Endocrinol Metab. 2010 Jan;95(1):215-21
references.pmid: 19892837
references.citation: J Endocrinol. 2013 Jul 29;218(3):255-62
references.pmid: 23757509
references.citation: Diabetes. 2004 Dec;53 Suppl 3:S215-9
references.pmid: 15561913
references.citation: Gastroenterology. 2009 Sep;137(3):997-1005, 1005.e1-4
references.pmid: 19482026
references.citation: Gastroenterology. 2007 May;132(6):2131-57
references.pmid: 17498508
references.citation: Regul Pept. 2014 Nov;194-195:6-10
references.pmid: 25218018
references.citation: Nat Med. 2000 Jul;6(7):802-7
references.pmid: 10888930
references.citation: Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R585-96
references.pmid: 24990862
references.citation: Metabolism. 2010 Aug;59(8):1092-105
references.pmid: 20060143
references.citation: Endocrinology. 2005 Apr;146(4):2069-76
references.pmid: 15618356
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G800-5
references.pmid: 19628655
references.citation: Diabetes. 1988 Sep;37(9):1163-7
references.pmid: 3044882
references.citation: Diabetes. 2003 Jan;52(1):102-10
references.pmid: 12502499
references.citation: J Endocrinol. 2012 Jun;213(3):277-84
references.pmid: 22457516
references.citation: Cell. 2013 Feb 14;152(4):673-84
references.pmid: 23415219
references.citation: Gastroenterology. 2010 Sep;139(3):857-68
references.pmid: 20546737
references.citation: Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G352-8
references.pmid: 22075777
references.citation: Ann N Y Acad Sci. 1999 Nov 18;892:146-54
references.pmid: 10842660
references.citation: Diabetologia. 2010 Mar;53(3):552-61
references.pmid: 19957161
references.citation: Curr Mol Med. 2005 May;5(3):287-95
references.pmid: 15892648
references.citation: Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E149-59
references.pmid: 23673159
references.citation: Mol Endocrinol. 2009 Jun;23(6):747-58
references.pmid: 19196831
references.citation: Drugs Context. 2015 Jul 09;4:212283
references.pmid: 26213556
references.citation: Gastroenterology. 2014 Dec;147(6):1275-1284.e4
references.pmid: 25173752
references.citation: Proc Natl Acad Sci U S A. 2007 May 22;104(21):8977-82
references.pmid: 17416680
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: J Endocrinol. 2013 Mar 15;217(1):11-20
references.pmid: 23308022
references.citation: Peptides. 2011 Jan;32(1):60-4
references.pmid: 20933560
references.citation: Scand J Gastroenterol. 1998 Aug;33(8):828-32
references.pmid: 9754730
references.citation: Cell Metab. 2013 Jul 2;18(1):86-98
references.pmid: 23823479
references.citation: Neurogastroenterol Motil. 2010 Jun;22(6):664-e203
references.pmid: 20158614
references.citation: J Endocrinol. 2014 Dec;223(3):R63-78
references.pmid: 25385879
references.citation: Diabetes. 2013 Feb;62(2):336-8
references.pmid: 23349538
references.citation: Am J Physiol Gastrointest Liver Physiol. 2010 Nov;299(5):G1038-44
references.pmid: 20705903
references.citation: J Clin Pharmacol. 2010 Jan;50(1):36-49
references.pmid: 19773525
references.citation: J Cell Physiol. 2015 Dec;230(12):3029-36
references.pmid: 25967277
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G678-84
references.pmid: 19109404
references.citation: Neurogastroenterol Motil. 2011 Sep;23(9):e383-92
references.pmid: 21752156
references.citation: Curr Opin Support Palliat Care. 2015 Jun;9(2):196-202
references.pmid: 25872118
references.citation: PLoS One. 2010 Dec 03;5(12):e14205
references.pmid: 21151924